Patient Reported Outcomes and Financial Toxicity in Head and Neck Cancer
This nonrandomized clinical trial assesses the utility of patient education materials and feasibility of longitudinal assessment of financial toxicity, quality of life, and out-of-pocket expenses in patients newly diagnosed nonmetastatic head and neck cancer undergoing radiation therapy.
Authors
- David M. Brizel (ORCID: https://orcid.org/0000-0001-9828-4790)
- Zihan Wan (ORCID: https://orcid.org/0009-0005-9359-6417)
- Donna Niedzwiecki (ORCID: https://orcid.org/0000-0002-3566-0450)
- Pooja Karukonda (ORCID: https://orcid.org/0000-0001-8358-3640)
- Fumiko Chino (ORCID: https://orcid.org/0000-0003-0498-488X)
- Yvonne M. Mowery
- Deborah Kaye
- Josephine Gaston
- Eileen Duffy
Institutions
- Maimonides Medical Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- Duke Medical Center (US)
- UPMC Hillman Cancer Center (US)
- Duke Cancer Institute
Publication Details
- Journal
- JAMA Oncology
- Published
- 2026-09-24
- DOI
- https://doi.org/10.1001/jamaoncol.2026.3615
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00